首页 > 最新文献

Casopis lekaru ceskych最新文献

英文 中文
Nutrition care in bariatric/metabolic surgery. 减肥/代谢手术中的营养护理。
Q4 Medicine Pub Date : 2022-01-01
Aneta Sadílková, Kristýna Čmerdová

The dietitian is an integral part of the multidisciplinary team of bariatric and metabolic surgery. The nutritional intervention is started already in the period of preparation for the bariatric procedure and focuses on the modification of the patient's current eating habits, weight reduction and understanding of the principles of the postoperative diet. After the bariatric procedure, the nutritional intervention ensures optimal nutrition of the patient within a specific diet regime implemented in the first weeks after the operation. However, nutritional care should continue at regular intervals for a long time after the procedure. It includes, for example, control of the appropriate diet composition, adherence to portion sizes and adequate drinking regime, as well as supplementation recommendations, all in relation to weight development, body composition and laboratory results.

营养师是减肥和代谢外科多学科团队不可或缺的一部分。营养干预在减肥手术的准备阶段就已经开始了,重点是改变患者目前的饮食习惯,减轻体重和了解术后饮食原则。在减肥手术后,营养干预确保患者在手术后第一周实施的特定饮食方案中获得最佳营养。然而,在手术后很长一段时间内,营养护理应定期进行。它包括,例如,控制适当的饮食组成,坚持份量和适当的饮酒制度,以及补充建议,所有这些都与体重发展,身体组成和实验室结果有关。
{"title":"Nutrition care in bariatric/metabolic surgery.","authors":"Aneta Sadílková,&nbsp;Kristýna Čmerdová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The dietitian is an integral part of the multidisciplinary team of bariatric and metabolic surgery. The nutritional intervention is started already in the period of preparation for the bariatric procedure and focuses on the modification of the patient&#39;s current eating habits, weight reduction and understanding of the principles of the postoperative diet. After the bariatric procedure, the nutritional intervention ensures optimal nutrition of the patient within a specific diet regime implemented in the first weeks after the operation. However, nutritional care should continue at regular intervals for a long time after the procedure. It includes, for example, control of the appropriate diet composition, adherence to portion sizes and adequate drinking regime, as well as supplementation recommendations, all in relation to weight development, body composition and laboratory results.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 3-4","pages":"114-117"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33473531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The importance of molecular autopsy in forensic medicine. 分子解剖在法医学中的重要性。
Q4 Medicine Pub Date : 2022-01-01
Jana Orlíčková, Martin Zeman, Tomáš Vojtíšek, Ondřej Slabý

Standard autopsy does not always detect a cause of individuals death. It occurs often in cases of sudden death. The reason for decease, at least in a part of unsolved cases, can be revealed using methods of molecular biology and genetics. This approach is called molecular autopsy. First application dates to the end of 20th century when cause of sudden unexplained death of a young woman was provided only after execution of molecular autopsy. Molecular autopsy (also known as post-mortem genetic testing) finds its application particularly in cases of sudden death of young people or infants as their decease is more frequently associated with hereditary diseases linked for example to heart or metabolic conditions. In terms of methodical development, the form of molecular testing has been improved until now. Originally, targeted analysis of small number of genes was used. Nowadays, whole-exome and whole-genome sequencing slowly becomes a new standard for molecular autopsy. Although molecular autopsy has a potential to be integrated into an autopsy as a standard part of it, for now it has not become a standardised routine part of forensic autopsy.

标准的尸检并不总能发现个人死亡的原因。它经常发生在突然死亡的病例中。死亡的原因,至少在部分悬案中,可以用分子生物学和遗传学的方法来揭示。这种方法被称为分子解剖。第一次应用是在20世纪末,当时一名年轻女子突然死亡的原因无法解释,只有在进行分子解剖后才提供。分子解剖(也称为死后基因检测)尤其适用于年轻人或婴儿猝死的情况,因为他们的死亡往往与遗传性疾病有关,例如与心脏或代谢疾病有关。在系统的发展方面,分子检测的形式已经得到了改进。最初,使用的是对少数基因的靶向分析。目前,全外显子组和全基因组测序逐渐成为分子解剖的新标准。虽然分子解剖有可能作为尸检的一个标准部分整合到尸检中,但目前它还没有成为法医尸检的一个标准化的常规部分。
{"title":"The importance of molecular autopsy in forensic medicine.","authors":"Jana Orlíčková,&nbsp;Martin Zeman,&nbsp;Tomáš Vojtíšek,&nbsp;Ondřej Slabý","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Standard autopsy does not always detect a cause of individuals death. It occurs often in cases of sudden death. The reason for decease, at least in a part of unsolved cases, can be revealed using methods of molecular biology and genetics. This approach is called molecular autopsy. First application dates to the end of 20th century when cause of sudden unexplained death of a young woman was provided only after execution of molecular autopsy. Molecular autopsy (also known as post-mortem genetic testing) finds its application particularly in cases of sudden death of young people or infants as their decease is more frequently associated with hereditary diseases linked for example to heart or metabolic conditions. In terms of methodical development, the form of molecular testing has been improved until now. Originally, targeted analysis of small number of genes was used. Nowadays, whole-exome and whole-genome sequencing slowly becomes a new standard for molecular autopsy. Although molecular autopsy has a potential to be integrated into an autopsy as a standard part of it, for now it has not become a standardised routine part of forensic autopsy.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 5","pages":"207-211"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40709006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic methods of fatty liver diseases. 脂肪肝的诊断方法。
Q4 Medicine Pub Date : 2022-01-01
Karel Dvořák

Fatty liver diseases represent the most common chronic liver diseases today. Therefore, the diagnostics of fatty liver is of great importance. Sonography is the most used imaging method in daily clinical practice for its availability and good diagnostic performance. But there are limitations in lower sensitivity in mild steatosis and in subjects with more severe obesity. Sonographic findings of fatty liver include higher echogenity of liver parenchyma and attenuation of ultrasound waves in deeper parts of the liver. Furthermore, there are some other advanced methods for semiquantitative and quantitative assessment of the amount of the liver fat. Many of them are based on acoustic signal attenuation assessment. The most broadly used is a CAP (controlled attenuation parameter) feature of FibroScan, which can assess fatty liver without classic ultrasound examination. Thera are also special MR based techniques - MR spectroscopy and PDFF (protein density fat fraction) which allow liver fat quantification with high precision and can be used as a reference standard.

脂肪肝是当今最常见的慢性肝病。因此,脂肪肝的诊断具有十分重要的意义。超声检查是临床上应用最广泛的影像学检查方法,具有实用性和较好的诊断效果。但在轻度脂肪变性和重度肥胖患者中,敏感性较低存在局限性。脂肪肝的超声表现包括肝实质高回声和肝深部超声衰减。此外,还有一些先进的半定量和定量评价肝脏脂肪量的方法。其中许多是基于声信号衰减评估。使用最广泛的是纤维扫描的CAP(受控衰减参数)特征,它可以在没有经典超声检查的情况下评估脂肪肝。还有一些特殊的基于MR的技术- MR光谱和PDFF(蛋白质密度脂肪分数),它们可以高精度地定量肝脏脂肪,并可作为参考标准。
{"title":"Diagnostic methods of fatty liver diseases.","authors":"Karel Dvořák","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Fatty liver diseases represent the most common chronic liver diseases today. Therefore, the diagnostics of fatty liver is of great importance. Sonography is the most used imaging method in daily clinical practice for its availability and good diagnostic performance. But there are limitations in lower sensitivity in mild steatosis and in subjects with more severe obesity. Sonographic findings of fatty liver include higher echogenity of liver parenchyma and attenuation of ultrasound waves in deeper parts of the liver. Furthermore, there are some other advanced methods for semiquantitative and quantitative assessment of the amount of the liver fat. Many of them are based on acoustic signal attenuation assessment. The most broadly used is a CAP (controlled attenuation parameter) feature of FibroScan, which can assess fatty liver without classic ultrasound examination. Thera are also special MR based techniques - MR spectroscopy and PDFF (protein density fat fraction) which allow liver fat quantification with high precision and can be used as a reference standard.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 2","pages":"57-60"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40149073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current issues of body donation for teaching and research purposes and their use in the Czech Republic. 为教学和研究目的而捐赠遗体的当前问题及其在捷克共和国的使用。
Q4 Medicine Pub Date : 2022-01-01
Jan Frišhons, Marek Joukal, Tomáš Vojtíšek, Petr Hájek, Mária Miklošová, Jiří Ferda, Ondřej Naňka, Jana Mrzílková, David Kachlík

Since time immemorial, bodies of deceased have been an integral part of teaching anatomy, and therefore the study of medicine. Without them, the teaching of anatomy, clinical anatomy and many research projects could not be realized. Nowadays, the European countries allow to use exclusively bodies of the deceased donors. Recently, we have registered a growing trend in the needs of the bodies not only for the purposes of medical education, but also for those of clinical anatomy. The question also arose of the suitability of using COVID-19 positive donors or the legislative possibility of obtaining bodies in the absence of donors in the donor program. Our communication addresses current issues of body donation for teaching and research purposes and their use in the Czech Republic.

自古以来,死者的尸体一直是解剖学教学的一个组成部分,因此也是医学研究的一个组成部分。没有他们,解剖学、临床解剖学的教学和许多科研项目都无法实现。如今,欧洲国家允许只使用已故捐赠者的遗体。最近,我们注意到一种日益增长的趋势,即对尸体的需求不仅是为了医学教育的目的,而且也是为了临床解剖学的目的。还出现了使用COVID-19阳性捐献者是否合适的问题,或在捐献者计划中没有捐献者的情况下获得尸体的立法可能性问题。我们的沟通解决了目前为教学和研究目的捐赠遗体及其在捷克共和国的使用问题。
{"title":"Current issues of body donation for teaching and research purposes and their use in the Czech Republic.","authors":"Jan Frišhons,&nbsp;Marek Joukal,&nbsp;Tomáš Vojtíšek,&nbsp;Petr Hájek,&nbsp;Mária Miklošová,&nbsp;Jiří Ferda,&nbsp;Ondřej Naňka,&nbsp;Jana Mrzílková,&nbsp;David Kachlík","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Since time immemorial, bodies of deceased have been an integral part of teaching anatomy, and therefore the study of medicine. Without them, the teaching of anatomy, clinical anatomy and many research projects could not be realized. Nowadays, the European countries allow to use exclusively bodies of the deceased donors. Recently, we have registered a growing trend in the needs of the bodies not only for the purposes of medical education, but also for those of clinical anatomy. The question also arose of the suitability of using COVID-19 positive donors or the legislative possibility of obtaining bodies in the absence of donors in the donor program. Our communication addresses current issues of body donation for teaching and research purposes and their use in the Czech Republic.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 3-4","pages":"153-158"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33465550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bartter and Gitelman syndromes. 巴特和吉特尔曼综合症。
Q4 Medicine Pub Date : 2022-01-01
Jakub Zieg, Zdeněk Doležel

Bartter and Gitelman syndromes belong to salt-losing tubulopathies. These rare diseases may be associated with severe electrolyte disorders. Early identification of tubulopathies is essential for appropriate management. Progress in molecular genetics enabled the identification of genes and pathophysiologic mechanisms associated with these diseases. Here, we review etiology and diagnostics of these disorders from the light of current knowledge. Additionally, we discuss contemporary therapeutic approaches.

Bartter和Gitelman综合征属于失盐小管病。这些罕见疾病可能与严重的电解质紊乱有关。早期发现管状病变对于适当的治疗至关重要。分子遗传学的进展使鉴定与这些疾病相关的基因和病理生理机制成为可能。在这里,我们从目前的知识回顾这些疾病的病因和诊断。此外,我们讨论当代的治疗方法。
{"title":"Bartter and Gitelman syndromes.","authors":"Jakub Zieg,&nbsp;Zdeněk Doležel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Bartter and Gitelman syndromes belong to salt-losing tubulopathies. These rare diseases may be associated with severe electrolyte disorders. Early identification of tubulopathies is essential for appropriate management. Progress in molecular genetics enabled the identification of genes and pathophysiologic mechanisms associated with these diseases. Here, we review etiology and diagnostics of these disorders from the light of current knowledge. Additionally, we discuss contemporary therapeutic approaches.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 3-4","pages":"131-134"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33473534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myocarditis as a manifestation of the disease COVID-19 and after vaccination against this disease. 心肌炎作为COVID-19疾病的表现和接种该疾病疫苗后。
Q4 Medicine Pub Date : 2022-01-01
Eliška Sovová

Although the involvement of the heart muscle in the coronavirus disease 2019 (COVID-19) is relatively common (5-10%), myocarditis is a complication with a much lower incidence, depending, however, on the diagnostic methods used. The pathophysiological mechanisms have been described, but there are significant gaps in current knowledge. Myocarditis in connection with vaccination against the disease COVID-19 is a separate nosological unit. Even here, the pathophysiological processes are not explored in detail. The incidence of this complication is estimated in the low tens per million vaccinated.

尽管2019冠状病毒病(COVID-19)中心肌的参与相对常见(5-10%),但心肌炎是一种发病率低得多的并发症,但这取决于所使用的诊断方法。病理生理机制已被描述,但在目前的知识有显著的差距。与COVID-19疫苗接种相关的心肌炎是一个单独的分类学单位。即使在这里,病理生理过程也没有详细探讨。据估计,这种并发症的发生率在接种疫苗的百万人中只有几十人。
{"title":"Myocarditis as a manifestation of the disease COVID-19 and after vaccination against this disease.","authors":"Eliška Sovová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although the involvement of the heart muscle in the coronavirus disease 2019 (COVID-19) is relatively common (5-10%), myocarditis is a complication with a much lower incidence, depending, however, on the diagnostic methods used. The pathophysiological mechanisms have been described, but there are significant gaps in current knowledge. Myocarditis in connection with vaccination against the disease COVID-19 is a separate nosological unit. Even here, the pathophysiological processes are not explored in detail. The incidence of this complication is estimated in the low tens per million vaccinated.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 3-4","pages":"135-138"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33473535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hippocratic Oath and current medical oaths. 希波克拉底誓言和现代医学誓言。
Q4 Medicine Pub Date : 2022-01-01
Sylva Fischerová, Martin Pohl

The so-called Hippocratic Oath is based on a standardized form of oath in the ancient world and is undoubtedly the most famous, most discussed and most commented part of the Corpus Hippocraticum, collection of medical writings whose authorship is traditionally attributed to the legendary physician Hippocrates. The study will first introduce the nature of this brief text and the various theories about the origins of the Oath, as well as the evidence for its earliest use. The second part of the study focuses on the history of medical oaths in Czechoslovakia since 1918, especially on the changes in the text of the oaths after 1948 (mainly on the basis of so far unpublished documents from the archives), and presents the form of current medical oaths in the Czech Republic, with reference to the formulations of the Hippocratic Oath itself; an overview table lists both the Czech and Latin versions of the current medical oaths.

所谓的希波克拉底誓言是基于古代世界的一种标准化的誓言形式,毫无疑问是《希波克拉底誓词大全》中最著名、讨论最多、评论最多的部分。《希波克拉底誓词大全》是医学著作的合集,其作者传统上被认为是传奇医生希波克拉底。这项研究将首先介绍这篇短文的性质,以及关于誓言起源的各种理论,以及它最早使用的证据。研究的第二部分侧重于1918年以来捷克斯洛伐克医学宣誓的历史,特别是1948年之后宣誓文本的变化(主要基于迄今未发表的档案文件),并介绍了捷克共和国目前医学宣誓的形式,参照希波克拉底誓言本身的措词;概述表列出了当前医学誓言的捷克语和拉丁语版本。
{"title":"Hippocratic Oath and current medical oaths.","authors":"Sylva Fischerová,&nbsp;Martin Pohl","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The so-called Hippocratic Oath is based on a standardized form of oath in the ancient world and is undoubtedly the most famous, most discussed and most commented part of the Corpus Hippocraticum, collection of medical writings whose authorship is traditionally attributed to the legendary physician Hippocrates. The study will first introduce the nature of this brief text and the various theories about the origins of the Oath, as well as the evidence for its earliest use. The second part of the study focuses on the history of medical oaths in Czechoslovakia since 1918, especially on the changes in the text of the oaths after 1948 (mainly on the basis of so far unpublished documents from the archives), and presents the form of current medical oaths in the Czech Republic, with reference to the formulations of the Hippocratic Oath itself; an overview table lists both the Czech and Latin versions of the current medical oaths.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 5","pages":"212-219"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40709007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Professor Josef Charvát and Informatics. 约瑟夫教授Charvát和信息学。
Q4 Medicine Pub Date : 2022-01-01
Štěpán Svačina

Professor Josef Charvát, a prominent internist and endocrinologist, has been following the issues of cybernetics and computers from the very beginning. In the difficult times of the 1950s, he was heavily involved in the organization of seminars and meetings of workers in technical and medical fields interested in cybernetics. Later, in his books for the general public, he foresaw a significant application of computers in medicine. His predictions are quite accurate even 50 years after the publication of these ideas.

约瑟夫教授Charvát,一位著名的内科医生和内分泌学家,从一开始就一直在关注控制论和计算机的问题。在20世纪50年代的困难时期,他积极参与组织技术和医学领域对控制论感兴趣的工人的研讨会和会议。后来,在他的大众读物中,他预见了计算机在医学上的重要应用。即使在这些观点发表50年后,他的预测仍然相当准确。
{"title":"Professor Josef Charvát and Informatics.","authors":"Štěpán Svačina","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Professor Josef Charvát, a prominent internist and endocrinologist, has been following the issues of cybernetics and computers from the very beginning. In the difficult times of the 1950s, he was heavily involved in the organization of seminars and meetings of workers in technical and medical fields interested in cybernetics. Later, in his books for the general public, he foresaw a significant application of computers in medicine. His predictions are quite accurate even 50 years after the publication of these ideas.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 5","pages":"191-193"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40515567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Graves ophthalmopathy - 2022 update. Graves眼病的管理- 2022年更新。
Q4 Medicine Pub Date : 2022-01-01
Jan Jiskra

Graves ophthalmopathy (GO) occurs in 25-50% cases of Graves disease. Most cases are just mild, only 5% represents eye threatening diseases. About 5-10% of cases could be euthyroid and 10% hypothyroid, respectively. All patients with GO should be assessed for activity (clinical activity score - CAS) and severity of the disease. Essential conditions of the successful treatment are well controlled thyroid dysfunction, smoking cessation and to refer patients with moderate to severe and sight threatening GO to specialized thyroid eye centers as soon as possible. Local therapy to maintain wet eye (lubricants) and supplementation of selenium deficiency is adequate in mild cases of GO. In cases of moderate to severe and sight threatening GO, administration of intravenous glucocorticoids in thyroid eye centers is first line treatment and a combination with mycophenolate or radiotherapy could be considered. When the first-line treatment fails or a contraindication/intolerance to them is present, non-steroid immunosuppressive drugs (mycophenolate, ciclosporin), rituximab, or radiotherapy could be considered. In rare cases of sight threatening GO urge surgical orbital decompression or tarsorrhaphy is warranted.

格雷夫斯眼病(GO)发生在25-50%的格雷夫斯病病例。大多数病例只是轻微的,只有5%是威胁眼睛的疾病。约5-10%的病例可表现为甲状腺功能正常,10%为甲状腺功能减退。所有GO患者都应进行活动评估(临床活动评分- CAS)和疾病严重程度。成功治疗的基本条件是控制好甲状腺功能障碍,戒烟,并将中度至重度和威胁视力的GO患者尽快转介到专门的甲状腺眼科中心。在轻度氧化石墨烯病例中,局部治疗以保持眼睛湿润(润滑剂)和补充硒缺乏是足够的。在中度至重度、危及视力的GO病例中,甲状腺眼中心静脉注射糖皮质激素是一线治疗方法,可考虑联合麦考酚酸盐或放疗。当一线治疗失败或存在禁忌症/不耐受时,可考虑使用非类固醇免疫抑制药物(霉酚酸盐、环孢素)、利妥昔单抗或放疗。在少数危及视力的病例中,迫切需要手术眼眶减压或睑板修补术。
{"title":"Management of Graves ophthalmopathy - 2022 update.","authors":"Jan Jiskra","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Graves ophthalmopathy (GO) occurs in 25-50% cases of Graves disease. Most cases are just mild, only 5% represents eye threatening diseases. About 5-10% of cases could be euthyroid and 10% hypothyroid, respectively. All patients with GO should be assessed for activity (clinical activity score - CAS) and severity of the disease. Essential conditions of the successful treatment are well controlled thyroid dysfunction, smoking cessation and to refer patients with moderate to severe and sight threatening GO to specialized thyroid eye centers as soon as possible. Local therapy to maintain wet eye (lubricants) and supplementation of selenium deficiency is adequate in mild cases of GO. In cases of moderate to severe and sight threatening GO, administration of intravenous glucocorticoids in thyroid eye centers is first line treatment and a combination with mycophenolate or radiotherapy could be considered. When the first-line treatment fails or a contraindication/intolerance to them is present, non-steroid immunosuppressive drugs (mycophenolate, ciclosporin), rituximab, or radiotherapy could be considered. In rare cases of sight threatening GO urge surgical orbital decompression or tarsorrhaphy is warranted.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 5","pages":"198-206"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40515569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current hepatitis C therapy. 目前的丙型肝炎治疗。
Q4 Medicine Pub Date : 2022-01-01
Petr Husa, Svatava Snopková, Petr Husa Ml

Hepatitis C virus (HCV) infection is still a major cause of chronic liver diseases, with approximately 71 million chronically infected persons worldwide. People who inject drugs currently or in the past (PWID), mostly intravenously, are the main risk group among HCV chronically infected persons. The efficacy of therapy with direct acting antivirals (DAA) is almost 100 %. Currently, the main mission is to diagnose HCV infection in the most possible number of infected persons; it is in collision with poor adherence of PWID in particular.

丙型肝炎病毒(HCV)感染仍然是慢性肝病的主要原因,全世界约有7100万慢性感染者。目前或过去注射毒品的人(PWID),主要是静脉注射,是丙型肝炎病毒慢性感染者中的主要危险群体。直接作用抗病毒药物(DAA)治疗的疗效几乎为100%。目前,主要任务是在尽可能多的感染者中诊断丙型肝炎感染;特别是与PWID的不良依从性相冲突。
{"title":"Current hepatitis C therapy.","authors":"Petr Husa,&nbsp;Svatava Snopková,&nbsp;Petr Husa Ml","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hepatitis C virus (HCV) infection is still a major cause of chronic liver diseases, with approximately 71 million chronically infected persons worldwide. People who inject drugs currently or in the past (PWID), mostly intravenously, are the main risk group among HCV chronically infected persons. The efficacy of therapy with direct acting antivirals (DAA) is almost 100 %. Currently, the main mission is to diagnose HCV infection in the most possible number of infected persons; it is in collision with poor adherence of PWID in particular.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 2","pages":"90-93"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40150632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Casopis lekaru ceskych
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1